Picture of Zai Lab logo

ZLAB — Zai Lab News Story

0.000.00%
us flag iconLast trade - 00:00
HealthcareAdventurousMid CapHigh Flyer

US-listed shares of Zai Lab slide after commencing $200 mln stock offering

** U.S.-listed shares of China-based drug developer Zai Lab
 ZLAB.O  fall 6% to $28.11 after the bell
    ** ZLAB commences public offering of $200 mln of American
depositary shares
    ** Company plans to use the proceeds for general corporate
purposes
    ** ZLAB has 98 mln outstanding shares, with a capitalization
of $3 bln market, according to data compiled by LSEG
    ** Goldman Sachs, Jefferies and Leerink Partners are the
joint book-running managers for the offering
    ** As of last close, ZLAB shares up 9.6% YTD

 (Reporting by Arasu Kannagi Basil in Bengaluru)
 ((ArasuKannagi.Basil@thomsonreuters.com;))

Recent news on Zai Lab

See all news